Think Different. Grow Different.

The medical device industry has never been short on innovation. Founders are building AI-powered diagnostics, breakthrough surgical technologies, patient-specific implants, and solutions that challenge decades of clinical status quo. And yet, when it comes time to commercialize that innovation, many of these same companies default to an approach that has not meaningfully changed in twenty years: buy advice at arm's length, stand up a 1099 field team, get a list of contacts, hope for introductions, and wait for results.

Healthcare has changed. Health systems have changed. Commercialization has to change with them.

Think Beyond Contacts

Having “a contact at a hospital” has never really been a strategy, and today it is less of one than ever. Modern purchasing decisions involve far more than a single physician relationship — value analysis committees, supply chain leaders, clinical stakeholders, contracting teams, GPOs, and executive leadership all shape whether a technology gets adopted.

Success requires understanding the entire process end to end, not simply knowing one person inside a building. Relationships can open a door. Understanding the process is what closes the deal on the other side of it.

Think Beyond Databases

Information alone stopped being an advantage some time ago. Every commercialization partner today has access to the same contact lists, the same market maps, the same directories of decision-makers. The differentiator was never having the data — it is knowing what to do with it.

Modern commercialization has to combine real operating experience, sharp market intelligence, and a genuine understanding of individual health system needs — and use that combination to prioritize targets and build smarter go-to-market strategies. The right question to ask a prospective commercialization partner isn't whether they have data. It's whether they know how to turn that data into growth.

The question isn't whether an advisory team has data. It's whether they know how to turn data into growth.

Think Beyond Outsourcing

A commercialization partner should not feel like a vendor. It should behave like an internal team member — understanding the technology deeply, participating in strategy discussions as a peer, anticipating obstacles before they surface, and representing the company with the same urgency and conviction its own founders bring to the work.

Customers should never be able to tell where a company's internal team ends and its commercialization partner begins.

Think Beyond Transactions

Early-stage healthcare companies do not need another report sitting in a shared drive. They need execution. They need partners who understand physician preference items, capital equipment approval cycles, GPO contracting, health system purchasing processes, and the day-to-day realities of bringing genuine innovation into a healthcare system built to resist change.

Most of all, they need partners who have lived it — not studied it from the outside.

---

Why Not Commercialize Differently?

If a company is genuinely trying to change healthcare, its commercialization approach should be just as willing to break from convention as its technology is.

At Healthcare Solutions US, that is the premise we start from. Startups building breakthrough technology deserve more than introductions. They deserve a strategy built around how healthcare actually buys, execution behind that strategy, and a team that works differently because the companies we serve are already working differently.

Breakthrough technology deserves breakthrough commercialization.